Jianfeng Qian
Papers
2
Total Citations
46
H-Index
2
About
Jianfeng Qian is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex pancreatic and periampullary tumors. His major contributions center on evaluating the safety and efficacy of robotic pancreaticoduodenectomy compared to traditional open surgery. Qian is best known for spearheading the PORTAL trial, a multicenter phase III non-inferiority randomized controlled study that investigates whether robotic approaches can match or surpass open surgery in perioperative outcomes. This landmark protocol paper has garnered 44 citations, underscoring its influence in shaping evidence-based surgical practice. Additionally, Qian has demonstrated technical innovation through a case report on robotic pancreaticoduodenectomy with hepatic artery reconstruction, proving its feasibility for patients with type 9 hepatic arterial anatomy—a challenging variant that often precludes minimally invasive options. His work bridges the gap between surgical innovation and rigorous clinical validation, offering hope for reduced recovery times and complications in high-risk patients. With a citation impact reflecting growing interest in robotic surgery, Qian continues to push boundaries in pancreatic oncology, making him a pivotal figure in the evolution of surgical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2